SVA
Price:
$6.47
Market Cap:
$464.94M
Sinovac Biotech Ltd., a biopharmaceutical company, focuses in the research, development, manufacture, and commercialization of vaccines against human infectious diseases in the People's Republic of China. The company's product portfolio includes vaccines against hepatitis A and B; hand, foot, and mouth diseases caused by enterovirus 71 (EV71); seasonal influenza; H5N1 and H1N1 pandemic influenza; coronavirus; varicella; and mumps. Its marketed products include Healive, an inactivated hepatitis A vaccine; Bilive, a combined inactivated hepatitis A and B vaccine; Anflu, a split viron influenza vaccine; Panflu, a vaccine against the H5N1 influenza virus; Panflu.1, a vaccine against the influenz...[Read more]
Industry
Biotechnology
IPO Date
2003-09-26
Stock Exchange
NASDAQ
Ticker
SVA
According to Sinovac Biotech Ltd.’s latest financial reports and current stock price. The company's current ROE is -1.13%. This represents a change of 2.37% compared to the average of -0.05% of the last 4 quarters.
The mean historical ROE of Sinovac Biotech Ltd. over the last ten years is 14.38%. The current -1.13% ROE has changed -107.88% with respect to the historical average. Over the past ten years (40 quarters), SVA's ROE was at its highest in in the June 2021 quarter at 86.98%. The ROE was at its lowest in in the June 2016 quarter at -8.55%.
Average
14.38%
Median
4.94%
Minimum
-1.20%
Maximum
90.78%
Discovering the peaks and valleys of Sinovac Biotech Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 513.99%
Maximum Annual ROE = 90.78%
Minimum Annual Increase = -3416.36%
Minimum Annual ROE = -1.20%
| Year | ROE | Change |
|---|---|---|
| 2023 | -1.15% | -189.89% |
| 2022 | 1.28% | -98.59% |
| 2021 | 90.78% | 513.99% |
| 2020 | 14.79% | -3.24% |
| 2019 | 15.28% | 77.79% |
| 2018 | 8.59% | -49.66% |
| 2017 | 17.07% | -3416.36% |
| 2016 | -0.51% | -55.77% |
| 2015 | -1.16% | -2.76% |
| 2014 | -1.20% | -120.70% |
The current ROE of Sinovac Biotech Ltd. (SVA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
30.30%
5-year avg
24.20%
10-year avg
14.38%
Sinovac Biotech Ltd.’s ROE is greater than iTeos Therapeutics, Inc. (-35.52%), greater than Invivyd, Inc. (-92.97%), greater than Sage Therapeutics, Inc. (-67.10%), less than Revance Therapeutics, Inc. (49.59%), less than Big Cypress Acquisition Corp. (53.70%), greater than Y-mAbs Therapeutics, Inc. (-24.60%), greater than Orchard Therapeutics plc (-5.12%), greater than Vigil Neuroscience, Inc. (-138.30%), greater than G1 Therapeutics, Inc. (-92.13%), less than Checkpoint Therapeutics, Inc. (916.24%),
| Company | ROE | Market cap |
|---|---|---|
| -35.52% | $448.68M | |
| -92.97% | $294.66M | |
| -67.10% | $544.94M | |
| 49.59% | $381.02M | |
| 53.70% | $425.36M | |
| -24.60% | $391.22M | |
| -5.12% | $380.11M | |
| -138.30% | $375.71M | |
| -92.13% | $377.75M | |
| 916.24% | $367.72M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sinovac Biotech Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sinovac Biotech Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Sinovac Biotech Ltd.'s ROE?
How is the ROE calculated for Sinovac Biotech Ltd. (SVA)?
What is the highest ROE for Sinovac Biotech Ltd. (SVA)?
What is the 3-year average ROE for Sinovac Biotech Ltd. (SVA)?
What is the 5-year average ROE for Sinovac Biotech Ltd. (SVA)?
How does the current ROE for Sinovac Biotech Ltd. (SVA) compare to its historical average?